Showing results (61-70 of 173) with videos related to
Sort By:
Pageof 18
Journal of Neurochemistry|November 1, 1985
A biochemical explanation of phenyl acetate neurotoxicity in experimental phenylketonuriaY H Loo, A Potempska, H M WisniewskiJournal of Neurochemistry|May 1, 1984
On the possible mechanism of phenylacetate neurotoxicity: inhibition of choline acetyltransferase by phenylacetyl-CoAA Potempska, Y H Loo, H M WisniewskiAdvances in Experimental Medicine and Biology|January 1, 1978
Myelin deficiency in experimental phenylketonuria: contribution of the aromatic acid metabolites of phenylalanineY H Loo, J Scotto, H M WisniewskiRevue D'Epidemiologie Et De Sante Publique|January 26, 2006
[Neuroleptic drug utilization among schizophrenic outpatients]P Blin, J-P Olié, D Sechter, et al.Therapie|January 1, 1995
[Undesirable effects of drugs. Epidemiologic study at a psychiatric service of a university hospital]P Vandel, P Bizouard, S Vandel, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 1994
Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophreniaJ M Leroux, E Elia, M Jacquet, et al.Fish & Shellfish Immunology|March 28, 2012
Cloning and functional characterisation of a peroxiredoxin 1 (NKEF A) cDNA from Atlantic salmon (Salmo salar) and its expression in fish infected with Neoparamoeba peruransGrace H Loo, Drew L Sutton, Kathryn A SchullerHuman Heredity|January 1, 1991
Phosphoglucomutase-1 polymorphism among Chinese in TaiwanM Lin-Chu, J H Loo, M A HaywardEuropean Journal of Clinical Pharmacology|January 19, 2000
Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypesP Vandel, E Haffen, S Vandel, et al.Pageof 18